# Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

> **NCT00238160** · PHASE3 · WITHDRAWN · sponsor: **Kyoto University**

## Conditions studied

- Localized Resectable Adult Primary Liver Cancer
- Stage III Childhood Liver Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** chemotherapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** hepatic arterial infusion
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT00238160
- **Lead sponsor:** Kyoto University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238160, "Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00238160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*